SCHEMBL29567200

SCHEMBL29567200

CNC(=O)c1cccc(Oc2cc(-c3c(C)cccc3C)nc(NS(=O)(=O)c3cnn(C)c3)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 3/20 0.43
▸ F2 P00734 1/20 0.43
▸ FGFR1 P11362 3/20 0.40
▸ EGFR P00533 2/20 0.40
▸ KDR P35968 2/20 0.40
▸ NR1H2 P55055 1/20 0.39
▸ NR1H3 Q13133 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LOXL2 Q9Y4K0 7/20 0.37
▸ LOX P28300 6/20 0.37
▸ ADCY10 Q96PN6 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CREBBP Q92793 1/20 0.36
▸ FGFR3 P22607 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310795 1.00 F10 (0.43) F10F2FGFR1EGFRKDR
SCHEMBL26810272 0.92 EGFR (0.38) F10F2FGFR1EGFRKDR
SCHEMBL29566644 0.91 FGFR1 (0.39) F10F2FGFR1EGFRKDR
SCHEMBL26874925 0.91 FGFR1 (0.39) F10F2FGFR1EGFRKDR
SCHEMBL29566952 0.89 FGFR1 (0.38) FGFR1EGFRKDRSMN1; SMN2ADCY10
SCHEMBL26810170 0.89 EGFR (0.38) FGFR1EGFRKDRSMN1; SMN2ADCY10
SCHEMBL24310553 0.89 FGFR1 (0.38) FGFR1EGFRKDRSMN1; SMN2ADCY10
SCHEMBL26810187 0.87 SLC6A9 (0.38) FGFR1EGFRKDR
SCHEMBL29566970 0.87 HRH3 (0.37) FGFR1EGFRKDRSMN1; SMN2
SCHEMBL24309468 0.87 HRH3 (0.37) FGFR1EGFRKDRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback